Cargando…
Barriers to clinical adoption of next generation sequencing: Perspectives of a policy Delphi panel
This research aims to inform policymakers by engaging expert stakeholders to identify, prioritize, and deliberate the most important and tractable policy barriers to the clinical adoption of next generation sequencing (NGS). A 4-round Delphi policy study was done with a multi-stakeholder panel of 48...
Autores principales: | Messner, Donna A., Al Naber, Jennifer, Koay, Pei, Cook-Deegan, Robert, Majumder, Mary, Javitt, Gail, Deverka, Patricia, Dvoskin, Rachel, Bollinger, Juli, Curnutte, Margaret, Chandrasekharan, Subhashini, McGuire, Amy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025465/ https://www.ncbi.nlm.nih.gov/pubmed/27668172 http://dx.doi.org/10.1016/j.atg.2016.05.004 |
Ejemplares similares
-
Challenges to Building a Gene Variant Commons to Assess Hereditary Cancer Risk: Results of a Modified Policy Delphi Panel Deliberation
por: Majumder, Mary A., et al.
Publicado: (2021) -
Policy options to facilitate cancer genomic variant data sharing: outcomes of a modified policy Delphi
por: Robinson, Jill O, et al.
Publicado: (2023) -
Gene patents and personalized medicine - what lies ahead?
por: Chandrasekharan, Subhashini, et al.
Publicado: (2009) -
Harm, hype and evidence: ELSI research and policy guidance
por: Caulfield, Timothy, et al.
Publicado: (2013) -
The continuing saga of patents and non‐invasive prenatal testing
por: Hawkins, Naomi, et al.
Publicado: (2019)